ナノメディシンの世界市場レポート 2025年

ナノメディシンの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は16.2％で、6,909億6,000万米ドルに成長します。予測期間の成長は、ナノテクノロジー研究の継続的な成長、ナノメディシン研究開発への投資の増加、個別化医療への注目の高まり、がん治療におけるナノメディシン応用の拡大、感染症治療におけるナノメディシンの統合に起因しています。予測期間における主な動向としては、治療薬や画像診断用の多機能ナノ粒子の開発、ナノ粒子をベースとした診断薬や画像診断薬の重視、再生医療におけるナノメディシンの応用、神経疾患の標的治療におけるナノメディシンの使用拡大、ナノメディシンの研究や商業化における共同研究やパートナーシップなどがあります。

世界中で慢性疾患の有病率の増加が予想され、予測期間中のナノメディシン市場の成長に貢献すると期待されています。ナノメディシンは、心血管障害、糖尿病、がん、認知症などの慢性疾患の治療において、体内での薬物の迅速な代謝を促進し、ますます不可欠なものとなりつつあります。特に、国際アルツハイマー病協会（Alzheimer's Disease International）の報告によると、認知症を患う人は世界で5,000万人を超え、その数は20年ごとに倍増し、2030年には8,000万人、2050年には1億5,200万人に達すると予測されています。また、世界のがん罹患者数は、2040年には新たに2,840万人が発症すると予測されています。慢性疾患の負担増は、ナノメディシンに基づく効果的な治療に対する需要を促進し、ナノメディシン市場の成長を促進します。

個別化医療に対する需要の高まりが、ナノメディシン市場の成長を促進すると予想されます。個別化医療は、個々の患者に合わせた医療判断や介入を行う革新的なアプローチであり、最先端技術によって治療成績や治療効果を向上させることが期待されています。2022年10月の報告によると、遺伝子検査製品は7万5,000種類以上、個別化医薬品は300種類以上となっています。このような個別化医療に対する需要の高まりが、ナノメディシン市場の成長を支える重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のナノメディシン市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のナノメディシン市場：成長率分析
• 世界のナノメディシン市場の実績：規模と成長、2019～2024年
• 世界のナノメディシン市場の予測：規模と成長、2024～2029年、2034年
• 世界のナノメディシン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のナノメディシン市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ナノ粒子
• ナノシェル
• ナノチューブ
• ナノデバイス
• その他
• 世界のナノメディシン市場：モダリティ別、実績と予測、2019～2024年、2024～2029年、2034年
• 診断
• 治療
• 世界のナノメディシン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床腫瘍学
• 感染症
• 臨床心臓病学
• 整形外科
• その他の用途
• 世界のナノメディシン市場：ナノ粒子のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 脂質ベースナノ粒子
• ポリマーナノ粒子
• 金属ナノ粒子
• セラミックナノ粒子
• 世界のナノメディシン市場：ナノシェルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 金ナノシェル
• 銀ナノシェル
• シリカナノシェル
• 世界のナノメディシン市場：ナノチューブのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• カーボンナノチューブ（CNT）
• ポリマーナノチューブ
• 世界のナノメディシン市場：ナノデバイスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ナノセンサー
• ナノロボット
• ナノスケール画像機器
• 世界のナノメディシン市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• デンドリマー
• 量子ドット
• ナノキャリア

第7章 地域別・国別分析

• 世界のナノメディシン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のナノメディシン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ナノメディシン市場：競合情勢
• ナノメディシン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ablynx NV Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Arrowhead Research Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Gate AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Celgene Corporation
• F. Hoffmann-La Roche AG
• GE Healthcare
• Gilead Sciences Inc.
• Merck AG
• Nanospectra Biosciences
• Nanotherapeutics Inc.
• NanoViricides Inc
• Novartis AG
• Sanofi S. A.
• Abraxis Bioscience Inc.
• Alnylam Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc.
• AuraSense Therapeutics LLC
• BIND Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ナノメディシン市場2029：新たな機会を提供する国
• ナノメディシン市場2029：新たな機会を提供するセグメント
• ナノメディシン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nanomedicine involves the application of nanotechnology in the field of medicine. It encompasses substances with sizes ranging from 1 to 100 nanometers, designed to precisely target tumor cells or critical immune cells. Nanomedicine serves as a crucial tool for personalized, targeted, and regenerative medicine, facilitating the delivery of enhanced new drugs, treatments, and implantable devices to both clinicians and patients.

The primary types of nanomedicine include nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles, specifically ultrafine particles typically between 1 and 100 nanometers in diameter, are commonly used in the production of medicines and drugs. Nanomedicine operates across different modalities such as diagnostics and treatments, finding applications in clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other medical fields.

The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanomedicine market size has grown rapidly in recent years. It will grow from $331.61 billion in 2024 to $379.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to increased understanding of molecular biology, growing incidence of chronic diseases, demand for targeted drug delivery systems, expansion of nanoparticle imaging technologies, growing aging population.

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $690.96 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to continued growth in nanotechnology research, rising investments in nanomedicine R&D, increasing focus on personalized medicine, expanding applications of nanomedicine in cancer treatment, integration of nanomedicine in infectious disease therapeutics. Major trends in the forecast period include development of multifunctional nanoparticles for therapeutics and imaging, emphasis on nanoparticle-based diagnostics and imaging agents, application of nanomedicine in regenerative medicine, growing use of nanomedicine in targeted therapy for neurological disorders, collaboration and partnerships in nanomedicine research and commercialization.

The anticipated increase in the prevalence of complex and chronic diseases worldwide is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is becoming increasingly integral in treating chronic conditions such as cardiovascular disorders, diabetes, cancer, and dementia, facilitating the rapid metabolism of drugs within the body. Notably, Alzheimer's Disease International reports that over 50 million people globally suffer from dementia, a number projected to double every 20 years, reaching 80 million by 2030 and 152 million by 2050. The global cancer burden is also predicted to escalate to 28.4 million new cases in 2040. The escalating burden of chronic diseases is poised to drive demand for effective therapeutic treatments based on nanomedicine, thereby fostering the growth of the nanomedicine market.

The growing demand for personalized medicine is expected to propel the nanomedicine market's growth. Personalized medicine, an innovative approach tailoring medical decisions and interventions to individual patients, holds the promise of improving outcomes and treatment efficacy through cutting-edge technology. Reports from October 2022 indicate more than 75,000 genetic testing products and 300 personalized medicines. This increasing demand for personalized medicine is a key driver behind the growth of the nanomedicine market.

Major players in the nanomedicine market are concentrating on innovative products, such as the dynapro zetastar, to enhance their market presence. This advanced instrument enables simultaneous measurements of dynamic and static light scattering, as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). For instance, Waters Corporation, a US-based analytical laboratory instruments and equipment company, launched the dynapro zetastar for nanoparticle analysis in September 2023. The instrument aids in the precise development of complex biologics by combining multiple light scattering techniques, offering adaptive data capture, automatic data quality assessment, and increased sensitivity and speed of measurements while using minimal sample volumes. The unique flow cell design allows connection to an autosampler, significantly enhancing laboratory productivity and efficiency by enabling unattended measurements for extended periods.

Innovative technologies, such as optical technology, are being employed by major companies in the nanomedicine market to drive revenues. Corning Incorporated, a US-based technology company, introduced corning videodrop in September 2023-an optical technique measuring the size and concentration of nanoparticles using interferometric microscopy. Videodrop is reliable, quick, and easy to use, with a label-free sample preparation process. The user-friendly software interface ensures smooth operation, and the method allows the quantification of concentration and size distribution without labeling. Viral vectors, including lentivirus, retrovirus, adenovirus, and extracellular vesicles (EVs), within the diameter range of 80-500 nanometers, can be physically titrated using this approach. The Videodrop technique serves as an effective in-process control during the purification process.

In November 2023, Celgene, a US-based integrated biopharmaceutical company dedicated to discovering and developing innovative therapies, acquired a stake in Nano Precision Medical for an undisclosed amount. This acquisition enhances Celgene's position in the nanomedicine market, enabling it to compete more effectively with other pharmaceutical companies that are also investing in innovative drug delivery solutions. Nano Precision Medical, also based in the US, specializes in producing miniaturized, subdermal drug implants using its proprietary NanoPortal technology.

Major companies operating in the nanomedicine market include Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

North America was the largest region in the nanomedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanomedicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanomedicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanomedicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nanomedicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Nanoparticles; Nanoshells; Nanotubes; Nanodevices; Other Types
• 2) By Modality: Diagnostics; Treatments
• 3) By Application: Clinical Oncology; Infectious Diseases; Clinical Cardiology; Orthopedics; Other Applications
• Subsegments:
• 1) By Nanoparticles: Lipid-Based Nanoparticles; Polymeric Nanoparticles; Metallic Nanoparticles; Ceramic Nanoparticles
• 2) By Nanoshells: Gold Nanoshells; Silver Nanoshells; Silica Nanoshells
• 3) By Nanotubes: Carbon Nanotubes (CNTs); Polymer Nanotubes
• 4) By Nanodevices: Nanosensors; Nanorobots; Nanoscale Imaging Devices
• 5) By Other Types: Dendrimers; Quantum Dots; Nanocarriers
• Companies Mentioned: Pfizer Inc.; Ablynx NV; Amgen Inc.; Arrowhead Research Inc.; Bio-Gate AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nanomedicine Market Characteristics

3. Nanomedicine Market Trends And Strategies

4. Nanomedicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nanomedicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nanomedicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nanomedicine Market Growth Rate Analysis
• 5.4. Global Nanomedicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nanomedicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nanomedicine Total Addressable Market (TAM)

6. Nanomedicine Market Segmentation

• 6.1. Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticles
• Nanoshells
• Nanotubes
• Nanodevices
• Other Types
• 6.2. Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Treatments
• 6.3. Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Oncology
• Infectious Diseases
• Clinical Cardiology
• Orthopedics
• Other Applications
• 6.4. Global Nanomedicine Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid-Based Nanoparticles
• Polymeric Nanoparticles
• Metallic Nanoparticles
• Ceramic Nanoparticles
• 6.5. Global Nanomedicine Market, Sub-Segmentation Of Nanoshells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gold Nanoshells
• Silver Nanoshells
• Silica Nanoshells
• 6.6. Global Nanomedicine Market, Sub-Segmentation Of Nanotubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbon Nanotubes (CNTs)
• Polymer Nanotubes
• 6.7. Global Nanomedicine Market, Sub-Segmentation Of Nanodevices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanosensors
• Nanorobots
• Nanoscale Imaging Devices
• 6.8. Global Nanomedicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dendrimers
• Quantum Dots
• Nanocarriers

7. Nanomedicine Market Regional And Country Analysis

• 7.1. Global Nanomedicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nanomedicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanomedicine Market

• 8.1. Asia-Pacific Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanomedicine Market

• 9.1. China Nanomedicine Market Overview
• 9.2. China Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanomedicine Market

• 10.1. India Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanomedicine Market

• 11.1. Japan Nanomedicine Market Overview
• 11.2. Japan Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanomedicine Market

• 12.1. Australia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanomedicine Market

• 13.1. Indonesia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanomedicine Market

• 14.1. South Korea Nanomedicine Market Overview
• 14.2. South Korea Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanomedicine Market

• 15.1. Western Europe Nanomedicine Market Overview
• 15.2. Western Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanomedicine Market

• 16.1. UK Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanomedicine Market

• 17.1. Germany Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanomedicine Market

• 18.1. France Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanomedicine Market

• 19.1. Italy Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanomedicine Market

• 20.1. Spain Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanomedicine Market

• 21.1. Eastern Europe Nanomedicine Market Overview
• 21.2. Eastern Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanomedicine Market

• 22.1. Russia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanomedicine Market

• 23.1. North America Nanomedicine Market Overview
• 23.2. North America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanomedicine Market

• 24.1. USA Nanomedicine Market Overview
• 24.2. USA Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanomedicine Market

• 25.1. Canada Nanomedicine Market Overview
• 25.2. Canada Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanomedicine Market

• 26.1. South America Nanomedicine Market Overview
• 26.2. South America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanomedicine Market

• 27.1. Brazil Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanomedicine Market

• 28.1. Middle East Nanomedicine Market Overview
• 28.2. Middle East Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanomedicine Market

• 29.1. Africa Nanomedicine Market Overview
• 29.2. Africa Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanomedicine Market Competitive Landscape And Company Profiles

• 30.1. Nanomedicine Market Competitive Landscape
• 30.2. Nanomedicine Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Ablynx NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Arrowhead Research Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Gate AG Overview, Products and Services, Strategy and Financial Analysis

31. Nanomedicine Market Other Major And Innovative Companies

• 31.1. Celgene Corporation
• 31.2. F. Hoffmann-La Roche AG
• 31.3. GE Healthcare
• 31.4. Gilead Sciences Inc.
• 31.5. Merck AG
• 31.6. Nanospectra Biosciences
• 31.7. Nanotherapeutics Inc.
• 31.8. NanoViricides Inc
• 31.9. Novartis AG
• 31.10. Sanofi S. A.
• 31.11. Abraxis Bioscience Inc.
• 31.12. Alnylam Pharmaceuticals Inc.
• 31.13. Arrowhead Pharmaceuticals Inc.
• 31.14. AuraSense Therapeutics LLC
• 31.15. BIND Therapeutics Inc.

32. Global Nanomedicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanomedicine Market

34. Recent Developments In The Nanomedicine Market

35. Nanomedicine Market High Potential Countries, Segments and Strategies

• 35.1 Nanomedicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nanomedicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nanomedicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer